Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "aet" 50+850 mg filmovertrukne tabletter
tiefenbacher gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "tiefenbacher" 50+850 mg filmovertrukne tabletter
alfred e. tiefenbacher gmbh & co. kg - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
vilmenio 50+850 mg filmovertrukne tabletter
axunio pharma gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
eucreas
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
zomarist
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
ciclosporin "actavis" 100 mg kapsler, bløde
actavis group ptc ehf. - ciclosporin - kapsler, bløde - 100 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
ciclosporin "actavis" 25 mg kapsler, bløde
actavis group ptc ehf. - ciclosporin - kapsler, bløde - 25 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
ciclosporin "actavis" 50 mg kapsler, bløde
actavis group ptc ehf. - ciclosporin - kapsler, bløde - 50 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "teva" 50+850 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg